QT Sense, a deep-tech biotech startup building tools to study living cells, announced it has secured €4 million in funding to accelerate its Quantum Nuova platform. This technology lets scientists observe cellular processes in real time and reveal biochemical activity linked to disease.

Funding Details

The funding includes a €3 million seed investment led by Cottonwood Technology Fund, with follow-on backing from existing investor QDNL Participations and an angel investor. In addition, the company received €600,000 from the ONCO-Q programme to support cancer research and €400,000 through the Quantum Forward Challenge for collaborative deployments with research partners.

Quantum Nuova: Real-time cellular observation

The Quantum Nuova platform aims to overcome the limitations of traditional lab methods, offering a more dynamic and precise view of cellular processes. This could lead to new discoveries in the field of medical research and the development of more effective therapies.